Harry Burn Sound Shore Management
Harry Burn is a co-founder of Sound Shore Management, a firm focused on large-cap value equities selected through fundamental research. Sound Shore is known for a disciplined valuation process and a relatively compact list of portfolio holdings. The firm is often cited among long-standing institutional value managers with a public-markets track record.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$118M |
| 2 |
Chevron
CVX
|
+$110M |
| 3 |
Pfizer
PFE
|
+$85.9M |
| 4 |
SIVB
SVB Financial Group
SIVB
|
+$49.4M |
| 5 |
Elanco Animal Health
ELAN
|
+$2.49M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$132M |
| 2 |
nVent Electric
NVT
|
+$98.9M |
| 3 |
Applied Materials
AMAT
|
+$97.6M |
| 4 |
Mohawk Industries
MHK
|
+$79.5M |
| 5 |
Lennar Class A
LEN
|
+$66.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 32.07% |
| 2 | Healthcare | 17.17% |
| 3 | Technology | 17.01% |
| 4 | Industrials | 8.7% |
| 5 | Energy | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Capital One
COF
$134B
| $191M | 4.45% |
1,853,346
-474,928
| -20% | -$45.8M |
|
2
Berkshire Hathaway Class B
BRK.B
$1.06T
| $178M | 4.16% |
786,902
-214,448
| -21% | -$46.6M |
|
3
Morgan Stanley
MS
$336B
| $178M | 4.15% |
3,474,627
-723,670
| -17% | -$34.3M |
|
4
Citigroup
C
$221B
| $167M | 3.91% |
2,096,416
-479,021
| -19% | -$35.4M |
|
5
Delta Air Lines
DAL
$54.2B
| $143M | 3.34% |
2,448,661
-566,652
| -19% | -$31.8M |
|
6
Merck
MRK
$376B
| $143M | 3.33% |
1,642,324
-117,226
| -7% | -$9.63M |
|
7
TotalEnergies
TTE
$199B
| $142M | 3.32% |
2,573,057
-162,228
| -6% | -$8.58M |
|
8
Perrigo
PRGO
$1.98B
| $141M | 3.29% |
2,728,823
+25,865
| +1% | +$1.35M |
|
9
UnitedHealth
UNH
$350B
| $141M | 3.29% |
479,109
-113,355
| -19% | -$29.7M |
|
10
Sabre
SABR
$848M
| $140M | 3.28% |
6,252,296
-1,151,057
| -16% | -$25.5M |
|
11
American International
AIG
$39.8B
| $139M | 3.25% |
2,708,096
-478,606
| -15% | -$25.4M |
|
12
Sensata Technologies
ST
$6.23B
| $135M | 3.15% |
2,504,273
-459,322
| -15% | -$23.6M |
|
|
SIVB
13
DELISTED
SVB Financial Group
SIVB
| $135M | 3.15% |
536,714
+217,141
| +68% | +$49.4M |
|
14
General Motors
GM
$77.2B
| $132M | 3.08% |
3,599,921
-67,926
| -2% | -$2.47M |
|
15
NXP Semiconductors
NXPI
$56.9B
| $131M | 3.05% |
1,025,629
-486,190
| -32% | -$56.4M |
|
16
Eaton
ETN
$163B
| $128M | 2.98% |
1,349,137
-349,633
| -21% | -$31M |
|
17
Bank of America
BAC
$431B
| $128M | 2.98% |
3,621,839
-753,453
| -17% | -$24.4M |
|
18
Comcast
CMCSA
$95.3B
| $120M | 2.81% |
2,674,652
-1,228,398
| -31% | -$54.7M |
|
19
Thermo Fisher Scientific
TMO
$233B
| $117M | 2.72% |
358,681
-90,338
| -20% | -$27.4M |
|
|
20
Oracle
ORCL
$422B
| $114M | 2.66% |
+2,150,785
| New | +$118M |
|
|
21
Lennar Class A
LEN
$21B
| $114M | 2.66% |
2,106,099
-1,163,872
| -36% | -$66.4M |
|
|
22
Applied Materials
AMAT
$391B
| $113M | 2.65% |
1,857,435
-1,737,107
| -48% | -$97.6M |
|
|
23
Chevron
CVX
$403B
| $112M | 2.62% |
+931,377
| New | +$110M |
|
|
24
Elanco Animal Health
ELAN
$12B
| $105M | 2.45% |
3,568,060
+91,580
| +3% | +$2.49M |
|
25
JetBlue
JBLU
$1.85B
| $102M | 2.38% |
5,439,457
-1,326,857
| -20% | -$24.7M |
|
Similar funds
Harry Burn's Q4 2019 Portfolio in Review
As of Q4 2019, Harry Burn held 39 positions worth $4.28B, down 11% from $4.81B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Harry Burn withdrew a net $866M in Q4 2019, closing 3 positions and reducing 29 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $132M position sold in full.
By sector, the portfolio is most concentrated in Financials at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Harry Burn opened a new position in Oracle worth $114M.
- Harry Burn's largest Q4 2019 buy was Oracle: 2,150,785 shares worth $114M.
- Harry Burn added most to SVB Financial Group in Q4 2019, an estimated $49.4M increase.
- Harry Burn's biggest Q4 2019 reduction was Applied Materials, cutting an estimated $97.6M.
- Harry Burn fully exited Alexion Pharmaceuticals in Q4 2019, selling an estimated $132M.
- Harry Burn's ten largest holdings make up 37% of its $4.28B portfolio in Q4 2019.
- Harry Burn opened 3 new positions and closed 3 in Q4 2019.
- Harry Burn's portfolio value fell 11% quarter-over-quarter to $4.28B.
Based on Sound Shore Management's 13F filing for Q4 2019, filed 6 Feb 2020.